Iterum Therapeutics plc (ITRM) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
4/25
Growth 2
Margin 2
Expansion 0
Platform 0
Financial 0
latest quarter score
Earnings Reports
- 4
- 6
- 6